LifeTech Capital invites you to their 1st Annual Miami Medical Investors Conference November 12th at the brand new JW Marriott Marquis Miami.
Browsing: Uncategorized
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
Minnesota-based orthopedics startup Dgimed Ortho is seeking to raise $2 million for its bone-fracture system.
It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.
If dementia care were a company, it would be the world’s largest in terms of annual revenue, surpassing even Wal-Mart.
Patients hoping for a new alternative to the blockbuster blood thinner Plavix will have to wait a bit longer for a verdict on a promising candidate.
Bristol-Myers Squibb Company (BMS) announced Tuesday that it had signed an agreement to acquire biopharmaceutical company ZymoGenetics for approximately $885 million, or $9.75 per share in cash.